Phenotypic Age Acceleration as a Mediator in Thyroid Hormone–Related Cardiovascular Risk Among the Elderly
Cardiology Research and Practice · 2026-01 · 2026 (1)
DOI: 10.1155/crp/1206757 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology Research and Practice, online erschienen am 28.06.2026. Verfasst von Minmin Wen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Translational Medicine of Ministry of Education & Hainan Provincial Key Laboratory for Tropical Cardiovascular Diseases Re…. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hainan Medical University.
Abstract (Originalsprache)
Background
The association between thyroid hormones and cardiovascular disease (CVD) has been widely examined; however, the role of biological aging in this relationship remains unclear. This study systematically investigates the mediating role of phenotypic age acceleration (PhenoAgeAccel) in the relationship between thyroid hormones and CVD.
Methods
The data were sourced from the 2007–2010 cycles of the National Health and Nutrition Examination Survey (NHANES). Analyses included logistic regression, linear regression, restricted cubic splines, subgroup analyses, and mediation analysis to assess the role of PhenoAgeAccel.
Results
Among participants aged ≥ 60 years, elevated free triiodothyronine (FT3) concentrations were linked to a reduced risk of CVD (adjusted odds ratio [aOR] = 0.483; 95% CI: 0.273–0.856; p = 0.013). Similarly, total triiodothyronine (TT3) levels were associated with a decreased CVD risk in those aged 60 and above (aOR = 0.988; 95% CI: 0.980–0.995; p = 0.013). Mediation analysis showed that PhenoAgeAccel mediated 21.13% of the FT3–CVD association and 23.41% of the TT3–CVD association in older adults.
Conclusion
This study identifies an age‐dependent relationship between FT3, TT3, and CVD and reveals that PhenoAgeAccel partially mediates this association. These findings suggest that interventions targeting thyroid function and biological aging may offer novel strategies for CVD prevention and management in older populations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Tropical Translational Medicine of Ministry of Education & Hainan Provincial Key Laboratory for Tropical Cardiovascular Diseases Research, School of Public Health, Hainan Medical University, Haikou, 57…
- Department of Cardiovascular Surgery, The Second Affiliated Hospital, Hainan Medical University, Haikou, 570100, China, hainmc.edu.cn.
- Department of Pathophysiology, School of Basic Medicine Sciences, Guangdong Medical University, Zhanjiang, 524023, China, gdmu.edu.cn.
ORCID-Profile: Kaijia Shi, Shuya Zhang, Zhihua Shen, Wei Jie
Förderung
- National Natural Science Foundation of China
- Hainan Medical University
Zitieren
APA
Wen, M., Hou, Y., Shi, K., Zuo, J., Zhang, C., Zhang, S., Shen, Z., & Jie, W. (2026). Phenotypic Age Acceleration as a Mediator in Thyroid Hormone–Related Cardiovascular Risk Among the Elderly. Cardiology Research and Practice, 2026(1). https://doi.org/10.1155/crp/1206757
Vancouver
Wen M, Hou Y, Shi K, Zuo J, Zhang C, Zhang S, et al. Phenotypic Age Acceleration as a Mediator in Thyroid Hormone–Related Cardiovascular Risk Among the Elderly. Cardiology Research and Practice. 2026;2026(1). doi:10.1155/crp/1206757
BibTeX
@article{Wen2026,
author = {Wen, Minmin and Hou, Yanjun and Shi, Kaijia and Zuo, Jiaxin and Zhang, Cheng and Zhang, Shuya and Shen, Zhihua and Jie, Wei},
title = {Phenotypic Age Acceleration as a Mediator in Thyroid Hormone–Related Cardiovascular Risk Among the Elderly},
journal = {Cardiology Research and Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crp/1206757}
}
EUVIMED